Portal Vein Embolization: Impact of Chemotherapy and Genetic Mutations
We characterized the effect of systemic therapy given after portal vein embolization (PVE) and before hepatectomy on hepatic tumor and functional liver remnant (FLR) volumes. All 76 patients who underwent right PVE from 2002–2016 were retrospectively studied. Etiologies included colorectal cancer (n...
Main Authors: | Deipolyi, Amy, Zhang, Yu, Naidu, Sailendra, Borad, Mitesh, Sahin, Burcu, Mathur, Amit, Oklu, Rahmi, Khademhosseini, Alireza |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
MDPI AG
2017
|
Online Access: | http://hdl.handle.net/1721.1/109898 |
Similar Items
-
Transcatheter Arterial Embolization and Continuous Intraarterial Infusion Chemotherapy in Hepatoma
by: Perpustakaan UGM, i-lib
Published: (1992) -
Recurrent pulmonary embolism: is filarial lymphedema a risk factor for deep vein thrombosis?
by: Boo, Yang Liang, et al.
Published: (2016) -
Concomitant fat embolism syndrome and pulmonary embolism in a patient with patent foramen ovale
by: Yeak, Raymond Dieu Kiat, et al.
Published: (2020) -
Point-of-care ultrasound in pre-bronchoscopy assessment of acute dyspnea: A case of concurrent massive pulmonary embolism and deep vein thrombosis
by: Mohammad Amirul Shahril Ahmad, et al.
Published: (2022) -
Fatal non-traumatic fat embolism
by: Mohtarrudin, Norhafizah, et al.
Published: (2020)